Conference Coverage
Conference Coverage
Antiviral may improve hearing loss in congenital CMV
Children with no other evident symptoms may gain hearing benefit from treatment.
Conference Coverage
Sporebiotics improve functional dyspepsia symptoms
“Studies like this may help us gain some insight into the cause of the problem,” commented Dr. Pankaj Jay Pasricha.
Conference Coverage
Some nasogastric intubation procedures lead to less aerosolization than feared
The results are important, one commenter said, but may not generalize to all procedures because of different equipment and protocols.
Conference Coverage
How early can laser treatment for port wine stains in infants be initiated?
“The early intervention allows for treatment without general anesthesia and it maximizes the chance of significant clearance as early in life as...
Conference Coverage
Vaping and pregnancy: Inhaled toxins among reasons for pause
Whether vaping is safer than smoking may be the wrong question to focus on, a researcher says.
Conference Coverage
GI symptoms and chronic fatigue may persist months after COVID-19
Loose stools, somatization, and chronic fatigue risks increased at a mean of 5 months after SARS-CoV-2 infection, suggesting a common...
Conference Coverage
High eradication, fewer adverse events with hybrid therapy for H. pylori
High-dose dual therapy had the lowest frequency of adverse events, but significantly lower eradication rates versus hybrid or quadruple therapies...
Conference Coverage
Head-to-head trial compares ustekinumab with adalimumab in Crohn’s
“With newer drugs, there’s a critical need for head-to-head studies for us to understand where to position a lot of these agents,”said Dr. Jordan...
Conference Coverage
Microbiome therapeutic offers durable protection against C. difficile recurrence
“The hope would be that one or more ... would probably replace the vast majority of FMT [procedures] that we do clinically,”said Dr. Sahil Khanna...
Conference Coverage
Intervention reduces PPI use without worsening acid-related diseases
“Many [previous] studies lack data on clinical outcomes, so it’s difficult to ascertain the real clinical benefits, or even harms.”
Conference Coverage
Liver transplant outcomes improving for U.S. patients with HIV/HCV
Hepatitis C virus infection no longer confers worse patient survival in the era of DAA therapy, but the population remains underserved.